2010Unpublished venueRequires access

IL-21 expression in hepatoma cell line H22 and its biological activity

Miao Nai-fa

Open publisher page 0 citations

Abstract

Objective:To construct a recombinant eukaryotic expression vector mIL-21-pcDNA3.1 and transfect it into hepatoma cell line H22, so as to assess the biological activity of mIL-21. Methods: The gene fragment encoding mouse IL-21 was amplified by RT-PCR, and was then cloned into eukaryotic expression plasmid pcDNA3.1 to form recombinant plasmid mIL-21-pcDNA3.1. The recombinant plasmid is verified by DNA sequencing. mIL-21-pcDNA3.1 was transfected into H22 cells with lipofect regent, and its expression was detected by RT-PCR and Western blotting analysis. The effects of mIL-21-pcDNA3.1 on proliferation of T cells and cytotoxicity of NK cells were studied. Results: The recombinant plasmid mIL-21-pcDNA3.1 was confirmed by DNA sequencing. The expression of mIL-21 in H22 cells was confirmed by RT-PCR and Western blotting analysis. MTT results showed that stimulation index (SI) of T cells stimulated with mIL-2-H22 cell supernatant was 3.412±0.312, and the SI of ConA combination stimulating group was 4.673±0.450; both were significantly higher than those in the mock vector transfected (1.465±0.103) and untransfected groups (1.447±0.245, P0.01). The cytotoxicity of NK cells in mIL-21-H22 cell supernatant group was (81.66±4.26)%, significantly higher than those in the mock vector transfected ([34.74±5.52]%) and untransfected groups ([33.61±1.42]%). Conclusion: The expression of mIL-21-pcDNA3.1 plasmid in H22 cells can enhance the proliferation of T cells and the cytotoxicity of NK cells, which lays a foundation for its role in the research of anti-hepatoma.

About this research paper

What this paper is about

Objective:To construct a recombinant eukaryotic expression vector mIL-21-pcDNA3.1 and transfect it into hepatoma cell line H22, so as to assess the biological activity of mIL-21. Methods: The gene fragment encoding mouse IL-21 was amplified by RT-PCR, and was then cloned into eukaryotic expression plasmid pcDNA3.1 to form recombinant plasmid mIL-21-pcDNA3.1. The recombinant plasmid is verified by DNA sequencing. mIL-21-pcDNA3.1 was transfected into H22 cells with lipofect regent, and its expression was detected by RT-PCR and Western blotting analysis. The effects of mIL-21-pcDNA3.1 on proliferation of T cells and cytotoxicity of NK cells were studied. Results: The recombinant plasmid mIL-21-pcDNA3.1 was confirmed by DNA sequencing. The expression of mIL-21 in H22 cells was confirmed by RT-PCR and Western blotting analysis. MTT results showed that stimulation index (SI) of T cells stimulated with mIL-2-H22 cell supernatant was 3.412±0.312, and the SI of ConA combination stimulating group was 4.673±0.450; both were significantly higher than those in the mock vector transfected (1.465±0.103) and untransfected groups (1.447±0.245, P0.01). The cytotoxicity of NK cells in mIL-21-H22 cell supernatant group was (81.66±4.26)%, significantly higher than those in the mock vector transfected ([34.74±5.52]%) and untransfected groups ([33.61±1.42]%). Conclusion: The expression of mIL-21-pcDNA3.1 plasmid in H22 cells can enhance the proliferation of T cells and the cytotoxicity of NK cells, which lays a foundation for its role in the research of anti-hepatoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To construct a recombinant eukaryotic expression vector mIL-21-pcDNA3.1 and transfect it into hepatoma cell line H22, so as to assess the biological activity of mIL-21. Methods: The gene fragment encoding mouse IL-21 was amplified by RT-PCR, and was then cloned into eukaryotic expression plasmid pcDNA3.1 to form recombinant plasmid mIL-21-pcDNA3.1. The recombinant plasmid is verified by DNA sequencing. mIL-21-pcDNA3.1 was transfected into H22 cells with lipofect regent, and its expression was detected by RT-PCR and Western blotting analysis. The effects of mIL-21-pcDNA3.1 on proliferation of T cells and cytotoxicity of NK cells were studied. Results: The recombinant plasmid mIL-21-pcDNA3.1 was confirmed by DNA sequencing. The expression of mIL-21 in H22 cells was confirmed by RT-PCR and Western blotting analysis. MTT results showed that stimulation index (SI) of T cells stimulated with mIL-2-H22 cell supernatant was 3.412±0.312, and the SI of ConA combination stimulating group was 4.673±0.450; both were significantly higher than those in the mock vector transfected (1.465±0.103) and untransfected groups (1.447±0.245, P0.01). The cytotoxicity of NK cells in mIL-21-H22 cell supernatant group was (81.66±4.26)%, significantly higher than those in the mock vector transfected ([34.74±5.52]%) and untransfected groups ([33.61±1.42]%). Conclusion: The expression of mIL-21-pcDNA3.1 plasmid in H22 cells can enhance the proliferation of T cells and the cytotoxicity of NK cells, which lays a foundation for its role in the research of anti-hepatoma.

Key concepts: Transfection, Recombinant DNA, Molecular biology, Plasmid, Blot, Cell culture, Cytotoxicity, Expression vector

Related papers

Back to paper searchBrowse research topicsOriginal source
IL-21 expression in hepatoma cell line H22 and its biological activity — Research Paper | ScholarLens